Clinical Trials
AstraZeneca and Lilly receive FDA Fast Track designation for AZD3293, an investigational treatment for early Alzheimer’s disease
AstraZeneca and Eli Lilly and Company (Lilly) announced they have received US FDA Fast Track designation for the development programme in Alzheimer’s disease for...
Press Releases
RRC Introducing The next-generation in chemical-free moisture analysis Computrac Vapor Pro XL
Arizona Instrument LLC is proud to announce the release of the Computrac® Vapor Pro® XL – the latest in a long line of accurate,...
Production & Manufacturing
Janssen Submits Application to U.S. FDA to Expand Indication for Daratumumab
Janssen Biotech, Inc. announced a supplemental Biologics License Application (sBLA) for daratumumab (DARZALEX®) has been submitted to the U.S. FDA . ...
Press Releases
FDA Approves Troxyca ER Capsules with Abuse-Deterrent Properties for the Management of Pain
Pfizer Inc announced that the U.S. Food and Drug Administration (FDA) has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules, for oral...
Drug Research
Researchers develop safer opioid painkiller from scratch
An international team of researchers - led by scientists at UC San Francisco, Stanford University, the University of North Carolina (UNC), and the Friedrich-Alexander...
Drug Research
ViiV Healthcare Begins Phase III Programme To Evaluate Two-drug Regimen For HIV-1 Treatment
ViiV Healthcare announced the start of a phase III programme to support regulatory filings for a two-drug regimen of dolutegravir (Tivicay®) and lamivudine (Epivir®)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read